JPRN-UMIN000002136已完成未知
Safety, efficacy and immunogenicity of autologous tumor lysate-pulsed dendritic cell therapy in patients with advanced renal cell carcinoma - Autologous tumor lysate-pulsed dendritic cell therapy for advanced renal cell carcinoma
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 15
研究概览
简要总结
Journal for ImmunoTherapy of Cancer.2014,2:30
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who have: - Pulmonary fibrosis or interstitial pneumonia, or history or predisposition of them; - Serious drug allergy; - Active infections; - Serious cardiac disease; - Active autoimmune diseases; - Continuous systemic administration of steroids within 4 weeks; - Other cancers.
研究者
相似试验
Unknown
1 期
Immunotherapy of Tumor With Autologous Tumor Derived Heat Shock Protein gp96Pancreatic AdenocarcinomaLiver CancerNCT02133079Cure&Sure Biotech Co., LTD20
进行中（未招募）
1 期
Study of TBI-1501 for Relapsed or Refractory Acute Lymphoblastic LeukemiaLymphoblastic Leukemia, Acute AdultNCT03155191Takara Bio Inc.21
招募中
1 期
TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Lung CancerLung Cancer MetastaticLung CancerLung Cancer, Non-small CellLung Cancer RecurrentNCT06538012Essen Biotech85
招募中
1 期
Biological Tumor Infiltrating Lymphocytes Therapy With Immunotherapy for Colon and Rectum CancerRectum CancerColorectal CancerColon CancerNCT06530303Essen Biotech85
招募中
1 期
TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Stomach and Esophageal CancerStomach Cancer RecurrentStomach Cancer, AdenocarcinomaEsophageal Cancer Metastatic to BoneEsophageal Cancer Metastatic to LungEsophageal Cancer Metastatic to LiverEsophageal CancerStomach CancerNCT06532799Essen Biotech75